US Stock MarketDetailed Quotes

Bio-Rad Laboratories (BIO)

Watchlist
  • 285.800
  • -6.640-2.27%
Trading Jun 12 12:04 ET
7.65BMarket Cap47.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bio-Rad Laboratories (BIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
1.14%592.1M
0.65%2.58B
3.85%693.2M
0.51%653M
2.05%651.6M
-4.16%585.4M
-3.92%2.57B
-2.00%667.5M
2.78%649.7M
-6.26%638.5M
Operating revenue
1.14%592.1M
0.65%2.58B
3.85%693.2M
0.51%653M
2.05%651.6M
-4.16%585.4M
-3.92%2.57B
-2.00%667.5M
2.78%649.7M
-6.26%638.5M
Cost of revenue
1.18%282.7M
4.69%1.24B
6.88%348M
5.38%309.6M
8.08%306.3M
-1.93%279.4M
-4.56%1.19B
3.43%325.6M
-0.89%293.8M
-11.06%283.4M
Gross profit
1.11%309.4M
-2.83%1.34B
0.97%345.2M
-3.51%343.4M
-2.76%345.3M
-6.11%306M
-3.36%1.38B
-6.67%341.9M
6.02%355.9M
-2.04%355.1M
Operating expense
-2.48%275.3M
1.03%1.12B
2.72%291.3M
-4.08%279.5M
5.76%268.2M
0.36%282.3M
1.91%1.11B
4.65%283.6M
19.07%291.4M
-7.06%253.6M
Selling and administrative expenses
1.72%212.4M
3.72%844.3M
8.33%221M
3.19%206.8M
6.68%207.7M
-2.84%208.8M
-3.29%814M
-1.51%204M
-0.40%200.4M
-6.31%194.7M
Research and development costs
-14.42%62.9M
-6.86%275.6M
-11.68%70.3M
-21.65%71.3M
2.72%60.5M
10.69%73.5M
19.60%295.9M
24.62%79.6M
109.03%91M
-9.44%58.9M
Provision for doubtful accounts
----
--1.4M
--0
--1.4M
----
----
--0
--0
--0
----
Operating profit
43.88%34.1M
-18.74%218.6M
-7.55%53.9M
-0.93%63.9M
-24.04%77.1M
-46.86%23.7M
-20.37%269M
-38.84%58.3M
-29.08%64.5M
13.26%101.5M
Net non-operating interest income expense
-64.05%8.7M
40.48%46.5M
410.81%18.9M
-57.58%1.4M
-51.16%2.1M
11.52%24.2M
-35.73%33.1M
-17.37%3.7M
-32.68%3.3M
3.44%4.3M
Non-operating interest income
-41.99%21M
16.46%95.5M
94.97%31M
-11.04%13.7M
-11.45%14.7M
6.47%36.2M
-18.73%82M
-5.36%15.9M
-10.98%15.4M
0.61%16.6M
Non-operating interest expense
2.50%12.3M
0.20%49M
-0.82%12.1M
1.65%12.3M
2.44%12.6M
-2.44%12M
-1.01%48.9M
-0.99%12.2M
-2.40%12.1M
-0.35%12.3M
Other net income (expense)
-2,163.66%-732.6M
127.62%730.4M
188.21%856.4M
-162.53%-496.4M
111.58%334.8M
-91.64%35.5M
-113.38%-2.64B
-395.50%-970.9M
1,826.47%793.8M
-81.42%-2.89B
Gain on sale of security
-2,195.14%-733.3M
134.31%908M
206.25%1.03B
-161.94%-491.4M
111.55%334.2M
-91.75%35M
-112.67%-2.65B
-395.10%-969.6M
1,987.36%793.3M
-81.43%-2.89B
Special income (charges)
----
---178.8M
---172.8M
---6M
----
----
--0
--0
--0
----
-Less:Impairment of capital assets
----
--172.8M
----
----
----
----
--0
----
----
----
-Write off
----
--6M
--0
--6M
----
----
--0
--0
--0
----
-Gain on sale of business
----
----
----
----
----
----
--0
--0
--0
----
Other non- operating income (expenses)
40.00%700K
-25.00%1.2M
23.08%-1M
100.00%1M
-64.71%600K
-37.50%500K
-33.33%1.6M
---1.3M
-28.57%500K
112.50%1.7M
Income before tax
-927.10%-689.8M
142.50%995.5M
202.23%929.2M
-150.03%-431.1M
114.86%414M
-83.02%83.4M
-175.56%-2.34B
-312.16%-908.9M
528.44%861.6M
-85.70%-2.79B
Income tax
-938.66%-162.7M
147.28%235.6M
208.34%209.2M
-142.80%-89.2M
115.50%96.2M
-81.90%19.4M
-134.16%-498.3M
-345.47%-193.1M
575.64%208.4M
-83.57%-620.8M
Net income
-923.59%-527.1M
141.20%759.9M
200.59%720M
-152.34%-341.9M
114.68%317.8M
-83.33%64M
-189.38%-1.84B
-304.67%-715.8M
514.74%653.2M
-86.32%-2.17B
Net income continuous Operations
-923.59%-527.1M
141.20%759.9M
200.59%720M
-152.34%-341.9M
114.68%317.8M
-83.33%64M
-189.38%-1.84B
-304.67%-715.8M
514.74%653.2M
-86.32%-2.17B
Minority interest income
Net income attributable to the parent company
-923.59%-527.1M
141.20%759.9M
200.59%720M
-152.34%-341.9M
114.68%317.8M
-83.33%64M
-189.38%-1.84B
-304.67%-715.8M
514.74%653.2M
-86.32%-2.17B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-923.59%-527.1M
141.20%759.9M
200.59%720M
-152.34%-341.9M
114.68%317.8M
-83.33%64M
-189.38%-1.84B
-304.67%-715.8M
514.74%653.2M
-86.32%-2.17B
Basic earnings per share
-953.71%-19.55
142.64%27.87
204.38%26.69
-154.34%-12.7
115.30%11.67
-82.99%2.29
-199.54%-65.36
-310.45%-25.57
540.27%23.37
-92.62%-76.26
Diluted earnings per share
-953.71%-19.55
142.61%27.85
204.22%26.65
-154.41%-12.7
115.30%11.67
-82.97%2.29
-199.54%-65.36
-310.63%-25.57
541.21%23.34
-92.62%-76.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 1.14%592.1M0.65%2.58B3.85%693.2M0.51%653M2.05%651.6M-4.16%585.4M-3.92%2.57B-2.00%667.5M2.78%649.7M-6.26%638.5M
Operating revenue 1.14%592.1M0.65%2.58B3.85%693.2M0.51%653M2.05%651.6M-4.16%585.4M-3.92%2.57B-2.00%667.5M2.78%649.7M-6.26%638.5M
Cost of revenue 1.18%282.7M4.69%1.24B6.88%348M5.38%309.6M8.08%306.3M-1.93%279.4M-4.56%1.19B3.43%325.6M-0.89%293.8M-11.06%283.4M
Gross profit 1.11%309.4M-2.83%1.34B0.97%345.2M-3.51%343.4M-2.76%345.3M-6.11%306M-3.36%1.38B-6.67%341.9M6.02%355.9M-2.04%355.1M
Operating expense -2.48%275.3M1.03%1.12B2.72%291.3M-4.08%279.5M5.76%268.2M0.36%282.3M1.91%1.11B4.65%283.6M19.07%291.4M-7.06%253.6M
Selling and administrative expenses 1.72%212.4M3.72%844.3M8.33%221M3.19%206.8M6.68%207.7M-2.84%208.8M-3.29%814M-1.51%204M-0.40%200.4M-6.31%194.7M
Research and development costs -14.42%62.9M-6.86%275.6M-11.68%70.3M-21.65%71.3M2.72%60.5M10.69%73.5M19.60%295.9M24.62%79.6M109.03%91M-9.44%58.9M
Provision for doubtful accounts ------1.4M--0--1.4M----------0--0--0----
Operating profit 43.88%34.1M-18.74%218.6M-7.55%53.9M-0.93%63.9M-24.04%77.1M-46.86%23.7M-20.37%269M-38.84%58.3M-29.08%64.5M13.26%101.5M
Net non-operating interest income expense -64.05%8.7M40.48%46.5M410.81%18.9M-57.58%1.4M-51.16%2.1M11.52%24.2M-35.73%33.1M-17.37%3.7M-32.68%3.3M3.44%4.3M
Non-operating interest income -41.99%21M16.46%95.5M94.97%31M-11.04%13.7M-11.45%14.7M6.47%36.2M-18.73%82M-5.36%15.9M-10.98%15.4M0.61%16.6M
Non-operating interest expense 2.50%12.3M0.20%49M-0.82%12.1M1.65%12.3M2.44%12.6M-2.44%12M-1.01%48.9M-0.99%12.2M-2.40%12.1M-0.35%12.3M
Other net income (expense) -2,163.66%-732.6M127.62%730.4M188.21%856.4M-162.53%-496.4M111.58%334.8M-91.64%35.5M-113.38%-2.64B-395.50%-970.9M1,826.47%793.8M-81.42%-2.89B
Gain on sale of security -2,195.14%-733.3M134.31%908M206.25%1.03B-161.94%-491.4M111.55%334.2M-91.75%35M-112.67%-2.65B-395.10%-969.6M1,987.36%793.3M-81.43%-2.89B
Special income (charges) -------178.8M---172.8M---6M----------0--0--0----
-Less:Impairment of capital assets ------172.8M------------------0------------
-Write off ------6M--0--6M----------0--0--0----
-Gain on sale of business --------------------------0--0--0----
Other non- operating income (expenses) 40.00%700K-25.00%1.2M23.08%-1M100.00%1M-64.71%600K-37.50%500K-33.33%1.6M---1.3M-28.57%500K112.50%1.7M
Income before tax -927.10%-689.8M142.50%995.5M202.23%929.2M-150.03%-431.1M114.86%414M-83.02%83.4M-175.56%-2.34B-312.16%-908.9M528.44%861.6M-85.70%-2.79B
Income tax -938.66%-162.7M147.28%235.6M208.34%209.2M-142.80%-89.2M115.50%96.2M-81.90%19.4M-134.16%-498.3M-345.47%-193.1M575.64%208.4M-83.57%-620.8M
Net income -923.59%-527.1M141.20%759.9M200.59%720M-152.34%-341.9M114.68%317.8M-83.33%64M-189.38%-1.84B-304.67%-715.8M514.74%653.2M-86.32%-2.17B
Net income continuous Operations -923.59%-527.1M141.20%759.9M200.59%720M-152.34%-341.9M114.68%317.8M-83.33%64M-189.38%-1.84B-304.67%-715.8M514.74%653.2M-86.32%-2.17B
Minority interest income
Net income attributable to the parent company -923.59%-527.1M141.20%759.9M200.59%720M-152.34%-341.9M114.68%317.8M-83.33%64M-189.38%-1.84B-304.67%-715.8M514.74%653.2M-86.32%-2.17B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -923.59%-527.1M141.20%759.9M200.59%720M-152.34%-341.9M114.68%317.8M-83.33%64M-189.38%-1.84B-304.67%-715.8M514.74%653.2M-86.32%-2.17B
Basic earnings per share -953.71%-19.55142.64%27.87204.38%26.69-154.34%-12.7115.30%11.67-82.99%2.29-199.54%-65.36-310.45%-25.57540.27%23.37-92.62%-76.26
Diluted earnings per share -953.71%-19.55142.61%27.85204.22%26.65-154.41%-12.7115.30%11.67-82.97%2.29-199.54%-65.36-310.63%-25.57541.21%23.34-92.62%-76.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.14%
Sample Name
Sample Code
 -0.53%
Sample Name
Sample Code
 -1.35%
4
ProShares Ultra Energy
DIG
-1.57%
5
VanEck Oil Services ETF
OIH
-2.39%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.14%
Sample Name
Sample Code
 +9.06%
Sample Name
Sample Code
 +7.17%
4
NetEase
NTES
+5.30%
5
Qifu Technology
QFIN
+5.20%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -